Journal of the American Chemical Society
Article
with nonfluorescent nanoemulsion and injected into the patient
for in vivo imaging.
Institutes of Health (P41-EB001977, P50-ES012359, R01-
CA139579, U54RR02224102). NMR instrumentation at CMU
was partially supported by NSF (CHE-0130903 and CHE-
1039870). Mass spectroscopy instrumentation at CMU was
funded by NSF (DBI-9729351).
Information about the fate of emulsions within the cells is
important to understanding the cell loading process and the
stability of the probe within cells over time. For example, if the
nanoemulsion enters the more acidic cellular environments,
such as the lysosomal compartments, the lower pH may lead to
break down of nanoemulsion components, including tracking
dyes and contrast agents, leading to loss of the labels within the
cells over hours or days in vivo. Additionally, the pH-sensing
reagent can report the health of cells that have engulfed the
emulsion, both in vitro and later in vivo following injection into
small animals. A common uptake mechanism of nanoreagent
delivery involves endocytosis,2 which results in drug payload
exposure to low pH in the lysosomes. The residence time of the
vehicle and the drug inside lysosomes can be measured with the
pH sensor incorporated into the formulation. This is important
for accurate determination of intracellular localization and the
nanoreagent fate. A number of pathways of internalization are
known, including clathrin-mediated endocytosis, pinocytosis,
phagocytosis, and micropinocytosis. Each mechanism differs in
the composition of the coat, size of the isolated vesicles, and the
fate of delivered substance.41 Endosomes may fuse with
lysosomes or may be recycled without significant acidification
to other compartments and the cell surface. Thus, development
of our pH-sensing nanoemulsion may make such studies central
to theranostic reagent development.
REFERENCES
■
(1) Godbey, W. T.; Wu, K. K.; Mikos, A. G. J. Controlled Release
1999, 60, 149.
(2) Kaneda, M. M.; Sasaki, Y.; Lanza, G. M.; Milbrandt, J.; Wickline,
S. A. Biomaterials 2010, 31, 3079.
(3) Briggs, M. S.; Burns, D. D.; Cooper, M. E.; Gregory, S. J.
ChemComm 2000, 2323−2324.
(4) Cooper, M. E.; Gregory, S.; Adie, E.; Kalinka, S. J. Fluoresc. 2002,
12, 425−429.
(5) Barriere, H.; Lukacs, G. L. Current Protocols in Cell Biology;
Bonifacino, J. S., Dasso, M., Eds.; John Wiley & Sons, Inc.: New York,
2008; Vol. 40, p 15.13.1−15.31.21.
(6) Han, J.; Burgess, K. Chem. Rev. 2009, 110, 2709−2728.
(7) Thomas, J. A.; Buchsbaum, R. N.; Zimniak, A.; Racker, E.
Biochemistry 1979, 18, 2210−2218.
(8) Schulz, A.; Hornig, S.; Liebert, T.; Birckner, E.; Heinze, T.; Mohr,
G. J. Org. Biomol. Chem. 2009, 7, 1884−1889.
(9) Mujumdar, R. B., Smith, J. A., US Patent 2000075237, 2000.
(10) Mujumdar, R. B., Smith, J. A., EU Patent 1212375, 2002.
(11) Mujumdar, R. B., Smith, J. A., EU Patent 1394219A1, 2004.
(12) Johnson, I.; Spence, M. T., The Molecular Probes Handbook: A
guide to fluorescent probes and labeling technologies; 11th ed.; Life
Technologies Corporation: Carlsbad, CA, 2010, pp 66−73.
(13) Grover, A.; Schmidt, B. F.; Salter, R. D.; Watkins, S. C.;
Waggoner, A. S.; Bruchez, M. P. Angew. Chem., Int. Ed. 2012, 51,
4838−4842.
(14) Ahrens, E. T.; Flores, R.; Xu, H. Y.; Morel, P. A. Nat. Biotechnol.
2005, 23, 983−987.
(15) Flogel, U.; Ding, Z.; Hardung, H.; Jander, S.; Reichmann, G.;
Jacoby, C.; Schubert, R.; Schrader, J. Circulation 2008, 118, 140−148.
(16) Janjic, J. M.; Ahrens, E. T. Wiley Interdiscip. Rev.: Nanomed.
Nanobiotechnol. 2009, 1, 492−501.
(17) Kadayakkara, D. K.; Beatty, P. L.; Turner, M. S.; Janjic, J. M.;
Ahrens, E. T.; Finn, O. J. Pancreas 2010, 39, 510−515.
(18) Srinivas, M.; Morel, P. A.; Ernst, L. A.; Laidlaw, D. H.; Ahrens,
E. T. Magn. Reson. Med. 2007, 58, 725−734.
(19) O’Hanlon, C. E.; Amede, K. G.; O’Hear, M. R.; Janjic, J. M. J.
Fluorine Chem. 2012, 137, 27−33.
(20) Patel, S. K.; Zhang, Y.; Pollock, J. A.; Janjic, J. M. PLoS ONE
2013, 8, e55802.
4. MATERIALS AND METHODS
Complete synthetic and experimental procedures are provided in
Supporting Information.
ASSOCIATED CONTENT
* Supporting Information
■
S
Synthetic procedures, analytical data, and experimental
analyses, including formulation performance. Detailed synthesis
of fluorescent reagents, PFPE oils and nanoemulsions,
spectroscopy, DLS and NMR (1H, 19F) data, and additional
discussion; further experimental assessment of nanoemulsions
for cell labeling applications; biological evaluation through 19F
NMR and fluorescence, flow cytometry analysis, and confocal
microscopy; intracellular pH measurement by flow cytometry.
This information is available free of charge via the Internet at
(21) Janjic, J. M.; Srinivas, M.; Kadayakkara, D. K.; Ahrens, E. T. J.
Am. Chem. Soc. 2008, 130, 2832−2841.
AUTHOR INFORMATION
Corresponding Author
■
(22) Janjic, J. M., Ahrens, E. T., US Patent 8227610, 2009.
(23) Mujumdar, R. B.; Ernst, L. A.; Mujumdar, S. R.; Lewis, C. J.;
Waggoner, A. S. Bioconjugate Chem. 1993, 4, 105−111.
(24) Zhang, W.; Curran, D. P. Tetrahedron 2006, 62, 11837−11865.
(25) Benolken, R. M.; Emery, J. M.; Landis, D. J. Invest. Ophthalmol.
1974, 13, 71−74.
Present Addresses
#Gastroenterology Department, Boston Children’s Hospital,
Boston, MA 02115.
(26) Hielscher, T. In Proceedings of European Nano Systems
Conference , Paris, France, December 14−16, 2005, EDA Publishing:
Cedex, France, 2005; pp 138-143.
∇Yale School of Medicine, New Haven, CT 06520.
¶Department of Radiology, University of California at San
Diego, La Jolla, CA 92093-0695.
(27) Taurozzi, J. S.; Hackley, V. A.; Wiesner, M. R. Preparation of
nanoparticle dispersions from powdered material using ultrasonic
disruption; U.S. Department of Commerce: Washington, D.C., 2012;
pp 1−15.
Notes
The authors declare no competing financial interest.
(28) Jares-Erijman, E. A.; Jovin, T. M. Nat. Biotechnol. 2003, 21,
1387−1395.
ACKNOWLEDGMENTS
■
The authors thank Kevin Hitchens, Hongyan Xu, Deepak
Kadayakkara, Virgil Simplaceau, Lauren A. Ernst, Mark E. Bier,
Frederick Lanni, James Fitzpatrick, and Yehuda Creeger for
their valuable assistance. This work was funded by the National
(29) Shu, D.; Zhang, H.; Petrenko, R.; Meller, J.; Guo, P. ACS Nano
2010, 4, 6843−6853.
(30) Hitchens, T. K.; Ye, Q.; Eytan, D. F.; Janjic, J. M.; Ahrens, E. T.;
Ho, C. Magn. Reson. Med. 2011, 65, 1145−1154.
18456
dx.doi.org/10.1021/ja407573m | J. Am. Chem. Soc. 2013, 135, 18445−18457